Rising interest in virus research tools

Picture of Dr Julio Rios de la Rosa

by Julio Rios de la Rosa

During the past month we have seen increased interest in our virus research reagents portfolio. This has doubtless been prompted by biotech companies responding to the COVID-19 crisis.

Although the reagents that Cambridge Enterprise has available do not relate directly to COVID-19, they are extremely helpful for advancing general virus research. They are well-established reagents, which have been researched and used in academic and commercial labs for years. Researchers can utilise them as a starting point for designing new detection kits and other relevant assays. Progression in this area could ultimately help to inform and speed up the research and development process around COVID-19.

Cambridge Enterprise has a range of virus reagents available to license non-exclusively, under standard terms and conditions. They fall into three main categories:

  • Murid Herpesvirus-4 (MuHV 4) antibodies
  • Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) antibodies
  • W-12 cell lines

To find out more, please download the marketing sheet and contact the Reagents Administrator.

Cambridge Enterprise also offers access to a wide range of other research reagents that are also available for commercial licensing. Please visit our available reagents page to find out more.

Photo credit  SciTechTrend

Tags: , , ,